The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
about
Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptidesCitrullination: a small change for a protein with great consequences for rheumatoid arthritisAntibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapyRheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentinStructural basis for histone N-terminal recognition by human peptidylarginine deiminase 4Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritisThe serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigensDiagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature reviewRheumatoid arthritis associated autoantibodies in patients with synovitis of recent onsetAnti-alpha-fodrin antibodies do not add much to the diagnosis of Sjögren's syndromeRole of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvementAre synovial biopsies of diagnostic value?Autoantibodies in normals--the value of predicting rheumatoid arthritisInsights into rheumatoid arthritis derived from the Sa immune system.The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma.Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic valueCitrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severityAnti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.Therapeutic implications of autoantibodies in rheumatoid arthritisMeta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody for juvenile idiopathic arthritisPathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLEThe effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responsesStructure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritisThe development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) iAn integrated peptide-antigen microarray on plasmonic gold films for sensitive human antibody profilingDetection of oral bacterial DNA in synovial fluid.A rheumatoid factor paradox: inhibition of rituximab effector function.Citrullination of myofilament proteins in heart failure.Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis.Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey.Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approachA case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity.The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.Rheumatoid arthritis, item response theory, Blom transformation, and mixed models.CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis.Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis.Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders.Evaluating epistatic interaction signals in complex traits using quantitative traits.Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases.
P2860
Q21146625-B1736859-84E4-412B-8B9B-75576DFC5F65Q21195246-2734BD70-5494-4A4C-B3D5-AD5B2CCF9171Q21195370-8279D173-B665-4A42-A0BE-66D67E4B631EQ21195679-30834F36-4A35-4262-BB7D-B3CCA44DC414Q24310773-3EAF4DD0-BFFF-49D0-8587-45EA84478187Q24538382-DAFEFD13-1AE8-4D1D-9093-A914A2E611A5Q24629328-42431B9C-25D5-402E-9F5D-5093721C595FQ24646963-5646142C-45EC-4E10-9D1C-83B053DF45FEQ24675281-8EA38FF1-9FB8-4F0E-BD4B-580B95529538Q24792419-EEFAF6AD-8236-4570-861E-305DFCBFC9FCQ24792981-94F295A8-4504-434A-BE62-04009627D48DQ24793557-FB64F41C-E8AF-4487-B338-1FD34CBF42FFQ24795018-21C04D96-35CF-49E4-B68B-133958208818Q24798609-1ECDDD3A-F097-49EE-AA2D-0223B7BB56A9Q24805044-3C0ED072-32CA-4F64-9FE9-48FB09118390Q24805333-5A8CD4C5-2740-452A-B8BA-B70F13997282Q24806041-BF849570-BC7C-4F13-BF6F-753E0858C76DQ24816615-89FDE0F5-9CEB-4F53-8C17-673D0E8CEAA8Q24816803-D46351EC-CF90-4CAD-A134-8B67BB48664BQ26744033-F1BFAF10-D5FF-4B1A-9F5C-819E5F44A7FBQ26991453-C229D60E-2C78-4570-AAD5-BDA9BA0E3F1AQ27003201-B7DE78AA-E3BE-48F4-9B53-CC2E6FFDAF6CQ27022645-A61412C5-5A4E-4E84-A718-B66ECDB83911Q27653688-9CB4AB78-06B4-412A-A401-C8D57503A9E1Q27672732-34274EC0-8DCA-4EA5-8602-FFEE140B13D0Q28534916-B760B4FF-034C-4FC8-AD4A-2F6A8FBD67CFQ30317854-49EDB829-CAA8-4C01-8A7B-79E1CA25B2A1Q30418884-162E9D49-3429-406E-B92A-ED85DA54DDB6Q30670009-BC2D6D79-2384-498F-9FB7-7287E0E13ADBQ32045081-3C59A086-AA17-4DD9-B9FC-0A271384F8D1Q33206727-2A6670FF-EBE3-4C89-8C93-1EBDD9B6EC71Q33264597-7AEC6CD0-8214-4D4A-934C-260C46FB0840Q33300467-7CD1F0DF-98AB-47AD-A3CB-3CE21E7FFBC1Q33332641-940FBF2F-B796-42D1-8AB4-57E8F00FF893Q33332775-D0FBAC2D-AA7A-4A3E-ADF4-0C767AFC781EQ33408519-1C6C903A-2A6F-4D16-BF41-1CA69EA729BCQ33419722-56CB5607-1B6E-4E91-93CF-A8F45A2C5CD2Q33420756-D37D3378-6EDF-48BF-9076-16E7D95AC15BQ33519387-DC80B281-8575-45E2-A6FA-560CB27CF114Q33526530-9C2ED38C-A03A-4578-99BA-0B973A87386E
P2860
The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
The diagnostic properties of r ...... cyclic citrullinated peptide.
@en
The diagnostic properties of r ...... cyclic citrullinated peptide.
@nl
type
label
The diagnostic properties of r ...... cyclic citrullinated peptide.
@en
The diagnostic properties of r ...... cyclic citrullinated peptide.
@nl
prefLabel
The diagnostic properties of r ...... cyclic citrullinated peptide.
@en
The diagnostic properties of r ...... cyclic citrullinated peptide.
@nl
P2093
P2860
P1476
The diagnostic properties of r ...... cyclic citrullinated peptide.
@en
P2093
Breedveld FC
Schellekens GA
de Jong BA
van Venrooij WJ
van den Hoogen FH
P2860
P304
P356
10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3
P577
2000-01-01T00:00:00Z